elotuzumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
EMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial AUST R: 260052Active ingredients:
elotuzumab
Dosage form:
Injection, powder for
Sponsor:
Bristol-Myers Squibb Australia Pty Ltd
Phone:
1800 067 567
|
From
16 Mar 2026
to
06 Apr 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
An alternatative strength is available, EMPLICITI elotuzumab 400mg lyophilized powder for IV infusion vial (260055)
|